Author Title [ Type(Desc)] Year
Filters: Author is Wu, De-Pei  [Clear All Filters]
Journal Article
Tao, T., Li, Z., Chu, X.-L., Zhu, W.-J., Xu, Y., Wu, D.-P., Ma, X., and Xue, S.-L. (2019). Clinical features of chronic graft-versus-host disease following haploidentical transplantation combined with infusion of a cord blood.Stem Cells Dev.
Yan, C.-H., Liu, Q.-F., Wu, D.-P., Zhang, X., Xu, L.-P., Zhang, X.-H., Wang, Y., Huang, H., Bai, H., Huang, F., et al. (2019). Corrigendum to 'Prophylactic donor lymphocyte infusion (DLI) followed by minimal residual disease and graft-versus host disease guided multiple DLIs could improve outcomes after allogeneic hematopoietic stem cell transplantation in patients with refractor.Biol Blood Marrow Transplant.
Zhu, X.-F., He, H.-L., Wang, S.-Q., Tang, J.-Y., Han, B., Zhang, D.-H., Wu, L.-Q., Wu, D.-P., Li, W., Xia, L.-H., et al. (2019). Current Treatment Patterns of Aplastic Anemia in China: A Prospective Cohort Registry Study.Acta Haematol1-9.
Xu, L.-P., Wang, S.-Q., Wu, D.-P., Wang, J.-M., Gao, S.-J., Jiang, M., Wang, C.-B., Zhang, X., Liu, Q.-F., Xia, L.-H., et al. (2016). Haplo-identical transplantation for acquired severe aplastic anaemia in a multicentre prospective study.Br J Haematol.
Xue, S.-L., Cui, H.-X., Zou, J.-Y., Xue, M.-X., Tang, X.-W., Zhang, Y.-M., and Wu, D.-P. (2013). Low-dose cytarabine and aclarubicin combined with granulocyte colony-stimulating factor for the treatment of relapsed or primary refractory acute lymphocytic leukemia: a retrospective study of 25 Chinese patients.Hematol Oncol.